Diversified Healthcare Trust DHC
8.13
0.01
0.12%
as of 25 Sep
- Market cap
- $2.0B
- P/E
- 0.0×
Follow DHC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.69 | 0.76 | 1.05 | 1.49 | |
P/FCF ratio |
5.49 | 2.76 | 3.64 | 20.88 | |
P/Operating CF |
(21.51) | (57.95) | 191.58 | 58.33 | |
P/B ratio |
0.63 | 0.70 | 0.99 | 1.41 | |
Price to Tangible BV |
0.63 | 0.70 | 0.99 | 1.41 | |
EV/Sales |
2.62 | 2.53 | 2.84 | 3.30 | |
EV/EBITDA |
29.06 | 28.85 | 29.85 | 30.79 | |
EV/Operating CF |
215.33 | (198.51) | (536.52) | (218.59) | |
EV/FCF |
20.82 | 9.21 | 9.82 | 46.21 | |
Quick Ratio |
16.89 | 4.10 | 5.36 | 4.67 | |
Current Ratio |
16.89 | 3.97 | 5.36 | 4.67 | |
Net Debt/EBITDA |
(105.97) | 38.13 | 37.36 | 35.22 | |
Debt/Assets |
58.14% | 55.05% | 56.28% | 56.69% | |
Debt/Equity |
1.61 | 1.44 | 1.48 | 1.52 | |
Asset Turnover |
0.31 | 0.32 | 0.33 | 0.33 | |
Operating CF/Net income |
0.30 | 0.95 | (0.19) | (1.03) | |
Capex/Depreciation |
(0.30) | 2.81 | (0.54) | (0.26) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.29% | 3.30% | 3.83% | 5.29% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(2.63) | (2.21) | (1.57) | (1.13) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(33.11%) | (24.54%) | (20.03%) | (11.94%) | |
Free Cash Flow Yield |
18.23% | 36.28% | 27.46% | 4.79% | |
Revenue per Share |
1.62 | 1.58 | 1.52 | 1.52 | |
Operating CF per Share |
(0.20) | (0.08) | 0.03 | 0.16 | |
Capex per Share |
(0.11) | 0.86 | (0.15) | (0.07) | |
Free Cash Flow per Share |
(0.31) | 0.78 | (0.11) | 0.09 | |
Cash per Share |
0.87 | 0.51 | 0.58 | 0.57 | |
Shareholders Equity per Share |
7.03 | 6.93 | 6.73 | 6.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.03 | 6.93 | 6.73 | 6.57 | |
Free Cash Flow |
(74.57) | 187.31 | (26.82) | 21.33 | |
Working Capital |
197.22 | 91.12 | 113.77 | 107.00 | |
Capital Expenditures |
(25.28) | 207.42 | (35.17) | (17.06) | |
Net Current Asset Value |
(2,785.62) | (2,573.88) | (2,507.28) | (2,519.67) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | (0.55) | 0.10 | 0.05 | |
Net Profit Margin |
(42.20%) | (5.59%) | (11.81%) | (10.24%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 2.98 | — | — | |
Average Payables |
— | 15.48 | — | — | |
Average Assets |
4,984.59 | 4,749.13 | 4,631.70 | 4,497.57 | |
Average Common Equity |
1,868.57 | 1,812.21 | 1,784.24 | 1,718.90 |
Columns are period end dates